SIGLEC15 and neoplasm: Strikingly, siRNA-mediated silencing of SIGLEC15 in SN increased the secretion of anti-tumor cytokines, including IL2, IFN-γ, and TNF-α, suggesting that inhibiting SIGLEC15 expression in SNs could restore T cell function.